查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1689874

无菌医疗包装：市场占有率分析、行业趋势和统计数据、成长预测（2025-2030 年）

Sterile Medical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 173 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 2025 年无菌医疗包装市场规模为 614.6 亿美元，到 2030 年将达到 922.5 亿美元，预测期内（2025-2030 年）的复合年增长率为 8.46%。

无菌医疗包装市场-IMG1

灭菌是医疗保健产业的关键过程。因此，无菌包装产品和无菌屏障系统在业界变得越来越重要。无菌医疗包装不可重复使用，可作为防止微生物感染的屏障。使用塑胶或纸张具有重量轻、可回收和耐用等优点。

主要亮点

  • 医疗和製药业对保护产品在运输过程中免受潮湿等环境因素影响的包装的需求日益增长。此外，对包装技术的投资不断增加，包括使用先进设备来提高效率，正在推动对确保医疗设备和药品完整性和无菌性的包装解决方案的需求。
  • 塑胶材料的进步正在推动市场的发展，塑胶被用于医疗设备和消耗品，包括个人防护设备。塑胶在基本医疗用品的生产、包装和分销中也发挥着至关重要的作用。各製药和医疗设备包装製造商正在透过引入更好的无菌包装解决方案不断改进产品系列。
  • 2024 年 1 月，全球微生物解决方案专家 Cherwell 宣布推出其突破性的 Redipor Beta Bag。这种创新的多用途塑胶袋可以降低与环境监测 (EM) 程序相关的风险、成本和时间，同时能够持续生产无菌药品。最近推出的转移袋已经过全面检验，设计用于与隔离器和 RABS 系统中常见的 190 毫米 Getinge Alpha 端口无缝配合。这确保了债权人电镀介质的无污染转移，从而实现了高效生产并显着降低了风险。
  • 处方药成本的上涨和日益增长的安全担忧导致非处方药（OTC）的流行。此外，疼痛、压力和皮肤病等某些疾病的增加也导致成药消费量的增加。成药的需求可能会增加整个製药业对无菌包装的需求。
  • 医疗无菌包装产业不能容忍任何污染或感染的可能性。因此，该行业在世界范围内受到严格监管，以确保产品免受污染或篡改，并准确显示剂量、製造和有效期等关键资讯。但在一个病人安全至关重要的行业中，遵守管理包装的详细标准有时会变得过于重要。包装法规的动态性质给该行业的製造商带来了挑战。

无菌医疗包装市场趋势

製药业占主要市场占有率

  • 过去几年，全球製药业取得了显着成长，这主要归功于技术进步和市场创新。根据美国国家医学图书馆的数据，FDA 预计在 2023 年核准55 种新药，这将推动市场成长。
  • 根据世界卫生组织（WHO）的资料，2019年60岁以上人口数为10亿，预计2030年将增加至14亿，到2050年将增加至21亿。人口老化加剧和医疗产品使用率高推动了製药业对无菌包装的需求。癌症、糖尿病、肠道疾病等需要长期使用药物的疾病的增加正在推动市场的成长。
  • 药品无菌包装可确保产品在整个供应链中无污染、无尘且安全，进而推动市场成长。热成型托盘、泡壳包装和小袋等包装有助于防止患者使用时有害细菌的传播。
  • 主要企业致力于透过无菌包装提供最高等级的保护。杜邦公司等公司提供具有高强度和微生物阻隔性能的无菌药品包装，以帮助在运输和储存过程中保持无菌。
  • 此外，根据IQVIA 2023年1月发布的报告，全球医疗保健和製药支出不断增加，2022年将达到约1.482兆美元。

亚太地区将经历大幅成长

  • 由于人们对医疗保健和医疗行业的关注度日益提高，预计亚太无菌包装市场将会成长。医疗产业需求的不断增长导致医疗设备和手术器械包装的繁荣。
  • 该地区无菌包装产业的发​​展归功于新兴的灭菌技术和智慧设计的包装解决方案推动市场成长。
  • 随着人口老化、慢性病增加以及医疗技术进步导致全球医疗保健产业持续成长，对无菌医疗设备包装的需求也预计将相应增加。这种增长进一步受到对感染控制和患者安全的日益关注的推动，这使得医疗设备製造商优先使用无菌包装来确保产品的完整性和无菌性。
  • 对病人安全的日益关注和对一次性医疗产品的需求不断增加，推动了对高品质无菌包装解决方案的需求。增强耐用性和阻隔性的无菌包装解决方案的创新也是全部区域的趋势。

无菌医疗包装市场概况

无菌医疗包装市场半固体，影响市场的因素多种多样，例如品牌识别、强大的竞争策略和透明度。由于强大的品牌意味着卓越的业绩，老字型大小企业有望占据优势。此外，大规模投资也提高了现有企业的退出门槛，推动产业竞争更加激烈。此外，供应商也不断提高技术力，加剧了市场竞争。该市场的参与企业包括 Amcor Group GmbH、Dupont De Nemours Inc.、Steripack Group Limited、Wipak Group 和 Placon Corporation。

  • 2024 年 4 月，杜邦宣布推出Tyvek Protec PSU 即剥即贴衬垫作为新型屋顶衬垫产品。这款新产品旨在提供高性能、耐高温和抗紫外线、防滑步行表面、易于使用的分隔衬垫、ICC-ES 代码报告和着名的 FL/Miami-Dade 认证。
  • 2024 年 2 月， 频谱宣布计划扩建其哥斯达黎加工厂，以包括无菌杜邦Tyvek医疗包装能力并加强其医疗导管业务。埃雷迪亚工厂面积从 36,000 平方英尺扩建至 52,000 平方英尺旨在提高生产能力并加快服务交付速度。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场洞察

  • 市场概览
  • 产业价值链分析
  • 产业吸引力－波特五力分析
  • 当前地缘政治情势如何影响市场

第五章市场动态

  • 市场驱动因素
    • 预计严格的感染控制法规将推动对无菌产品的需求
    • 近期产能增加
    • 塑胶领域的材料进步
  • 市场挑战
    • 法规的动态性质要求製造商解决造成材料供应问题的当地因素

第六章市场区隔

  • 依材料类型
    • 塑胶
      • 聚丙烯（PP）
      • 聚酯纤维
      • 聚苯乙烯（PS）
      • 聚氯乙烯（PVC）、高密度聚苯乙烯（HDPE）等。
    • 纸和纸板
    • 玻璃
    • 其他材料
  • 依产品类型
    • 热成型托盘
    • 无菌瓶子和容器
    • 袋子和包包
    • 泡壳包装
    • 管瓶和安瓿瓶
    • 预填充式注射器
    • 裹
  • 按应用
    • 製药
    • 手术和医疗器械
    • 体外诊断（IVD）
    • 其他用途
  • 按灭菌类型
    • 化学灭菌
    • 放射线杀菌
    • 压力和温度灭菌
  • 按地区
    • 北美洲
    • 欧洲
    • 亚洲
    • 澳洲和纽西兰
    • 拉丁美洲
    • 中东和非洲

第七章竞争格局

  • 公司简介
    • Amcor Group GmbH
    • Dupont De Nemours Inc.
    • Steripack Group Limited
    • Wipak Group
    • Placon Corporation
    • Riverside Medical Packaging Company Ltd
    • Tekni-Plex Inc.
    • BillerudKorsnas AB
    • Sonoco Products Co
    • DWK Life Sciences
    • Technipaq Inc.
    • 3M Company
    • Nelipak Healthcare Packaging
    • Oliver Healthcare Packaging
    • Beacon Converting Inc.
    • Paxxus Inc.
    • Spectrum Plastics Group
    • Sterimed Holdings SaS
    • Sigma Medical Supplies Corporation
    • Charter Next Generation
    • Berry Global Inc.
    • Sealed Air Corporation

第八章 市场展望

简介目录
Product Code: 69033

The Sterile Medical Packaging Market size is estimated at USD 61.46 billion in 2025, and is expected to reach USD 92.25 billion by 2030, at a CAGR of 8.46% during the forecast period (2025-2030).

Sterile Medical Packaging - Market - IMG1

Sterilization is an important processing step in the healthcare industry. Therefore, sterile packaging products or sterile barrier systems are becoming increasingly important in the industry. Sterile medical packaging is non-reusable and acts as a barrier against microbial infection. Using plastic and paper offers lightweight, recyclability, and durability advantages.

Key Highlights

  • The medical and pharmaceutical industries are experiencing a growing need for packaging to safeguard products from environmental factors like moisture while in transit. Additionally, the rising investments in packaging technologies, including the use of advanced equipment to enhance efficiency, are driving up the demand for packaging solutions that guarantee the integrity and sterility of medical devices and pharmaceuticals.
  • Material advancements in plastics drive the market, using plastics in medical devices and supplies, including personal protective equipment. Plastics are also crucial in essential medical production, packaging, and distribution. Various pharmaceutical and medical device packaging manufacturers are constantly improving their product portfolio by introducing better sterile packaging solutions.
  • In January 2024, global microbiology solution expert Cherwell announced the launch of the groundbreaking Redipor Beta Bag. This innovative plastic bag for multiple uses has the potential to decrease risk, expenses, and time involved in environmental monitoring (EM) procedures while continuously manufacturing sterile medicinal products. The recently introduced transfer bags have been thoroughly validated and are designed to work seamlessly with 190mm Getinge Alpha Ports commonly found in isolators and RABS systems. This ensures a contamination-free transfer of creditor-plated media, allowing for efficient production and a notable decrease in risk.
  • The over-the-counter (OTC) popularity is growing because of the rising prescription drug costs and increasing concerns over safety. Further, the increase in certain disorders, such as those related to pain, stress, and skin conditions, contributes to the growing consumption of OTC drugs. The demand for OTC drugs will likely increase the demand for sterile packaging across the pharmaceutical industry.
  • The medical sterile packaging sector doesn't allow any room chances for contamination and infections. Therefore, the sector is strictly regulated globally to guarantee the safety of products from contamination and tampering and to ensure that vital information regarding dosage, usage, manufacturing, expiration dates, and other details is accurately presented. However, in an industry where patient safety is paramount, following detailed criteria that control the packaging sometimes becomes overly critical. The dynamic nature of packaging regulations makes it challenging for the manufacturers in the industry.

Sterile Medical Packaging Market Trends

Pharmaceutical Sector to Hold Major Market Share

  • The global pharmaceutical industry has experienced significant growth in the past years, mainly due to technological advancements and innovations in the market. According to the National Library of Medicine, the FDA approved 55 new drugs in 2023, which drives the market's growth.
  • According to data from the World Health Organization, the number of people aged 60 years and older in 2019 was 1 billion, which is likely to increase to 1.4 billion by 2030 and 2.1 billion by 2050, rspectively. The demand for sterile packaging in the pharmaceutical industry is attributable to the rising aging population with high medical product use. Growth in diseases, including cancer, diabetes, and bowel diseases, requires long-term use of medicines and drugs, thus boosting the market's growth.
  • The pharmaceutical sterile packaging for drugs and medicines ensures the products are contamination, dust-free, and secure during the supply chain, propelling the market growth. Packaging such as thermoform trays, blister packs, and pouches help prevent the spread of harmful germs used by patients.
  • Major players strive to provide the highest level of protection through sterile packaging. Companies such as DuPont de Nemours Inc. provide pharmaceutical sterile packaging with high strength and microbial barriers to help preserve sterility during shipping and storage.
  • Furthermore, according to the IQVIA report published on January 2023, global spending on medicine and pharmaceuticals is constantly growing, with approximately USD 1.482 trillion in 2022; encouragingly, the pharmaceutical and medical expenditure is expected to increase to around 1.917 trillion by 2027.

Asia Pacific to Register Major Growth

  • The sterile packaging market in Aisa pacific, is estimated to rise due to the growing emphasis on the healthcare and medical industry. The rising demand for the medical industry has resulted in a boom in the packaging of medical devices and surgical instruments.
  • The development in the sterile packaging industry in the region is attributable to the rising advancements in sterilization technologies and intelligent design packaging solutions that boost the market's growth.
  • As the healthcare industry continues to grow globally, driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology, the demand for sterile medical device packaging is expected to rise correspondingly. This growth is further driven by the heightened emphasis on infection control and patient safety, prompting medical device manufacturers to prioritize the use of sterile packaging to ensure the integrity and sterility of their products.
  • Increasing emphasis on patient safety and rising demand for single-use medical products has resulted in a growing demand for high-quality sterile packaging solutions. Technological innovation in sterile packaging solutions with enhanced durability and barrier properties is also trending across the region.

Sterile Medical Packaging Market Overview

The sterile medical packaging market is semi-consolidated with various factors affecting the market, such as brand identity, powerful competitive strategy, and degree of transparency. Strong brands are synonymous with good performance, so long-standing players are expected to have the upper hand. Moreover, the involvement of large-scale investment also increases the barriers to exit for existing players, thereby pushing the industry toward improved competition. Additionally, vendors are enhancing their technological capabilities, thereby intensifying market competition. Some of the players in the market are Amcor Group GmbH, Dupont De Nemours Inc.,Steripack Group Limited, Wipak Group, Placon Corporation

  • In April 2024, DuPont announced the launch of the addition of its roofing underlayment product line, the Tyvek Protec PSU peel-and-stick underlayment. The new product is designed to provide high-performance, high-temperature, and UV resistance, a slip-resistant walking surface, a split liner for easy installation, an ICC-ES code report, and prestigious FL/Miami-Dade certification.
  • In February 2024, Spectrum announced plans to expand its facility in Costa Rica, incorporating sterile DuPont Tyvek medical packaging capabilities and enhancing its medical tubing operations. The expansion of the Heredia facility from 36,000 square feet to 52,000 square feet aims to increase capacity and expedite service delivery.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.4 Impact of the Current Geo-political Scenarios on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Stringent Regulations Toward Infection Control Expected to Aid Demand for Sterile-based Products
    • 5.1.2 Recent Increase in Utilization Capacity
    • 5.1.3 Material Advancements in the Field of Plastics
  • 5.2 Market Challenges
    • 5.2.1 Dynamic Nature of Regulations Makes it Challenging for Manufacturers to Comply with Local Factors with Issues Related to Material Availability

6 MARKET SEGMENTATION

  • 6.1 By Material Type
    • 6.1.1 Plastic
      • 6.1.1.1 Polypropylene (PP)
      • 6.1.1.2 Polyester
      • 6.1.1.3 Polystyrene (PS)
      • 6.1.1.4 Polyvinyl Chloride (PVC), High-density Polyethylene (HDPE), etc
    • 6.1.2 Paper and Paperboard
    • 6.1.3 Glass
    • 6.1.4 Other Material Types
  • 6.2 By Product Type
    • 6.2.1 Thermoform Trays
    • 6.2.2 Sterile Bottles and Containers
    • 6.2.3 Pouches and Bags
    • 6.2.4 Blisters Packs
    • 6.2.5 Vials and Ampoules
    • 6.2.6 Pre-Filled Syringes
    • 6.2.7 Wraps
  • 6.3 By Application Type
    • 6.3.1 Pharmaceutical
    • 6.3.2 Surgical and Medical Appliances
    • 6.3.3 In Vitro Diagnostics (IVD)
    • 6.3.4 Other Applications
  • 6.4 By Sterilization Type
    • 6.4.1 Chemical Sterilization
    • 6.4.2 Radiation Sterilization
    • 6.4.3 Pressure/Temperature Sterilization
  • 6.5 By Geography
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia
    • 6.5.4 Australia and New Zealand
    • 6.5.5 Latin America
    • 6.5.6 Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Amcor Group GmbH
    • 7.1.2 Dupont De Nemours Inc.
    • 7.1.3 Steripack Group Limited
    • 7.1.4 Wipak Group
    • 7.1.5 Placon Corporation
    • 7.1.6 Riverside Medical Packaging Company Ltd
    • 7.1.7 Tekni-Plex Inc.
    • 7.1.8 BillerudKorsnas AB
    • 7.1.9 Sonoco Products Co
    • 7.1.10 DWK Life Sciences
    • 7.1.11 Technipaq Inc.
    • 7.1.12 3M Company
    • 7.1.13 Nelipak Healthcare Packaging
    • 7.1.14 Oliver Healthcare Packaging
    • 7.1.15 Beacon Converting Inc.
    • 7.1.16 Paxxus Inc.
    • 7.1.17 Spectrum Plastics Group
    • 7.1.18 Sterimed Holdings SaS
    • 7.1.19 Sigma Medical Supplies Corporation
    • 7.1.20 Charter Next Generation
    • 7.1.21 Berry Global Inc.
    • 7.1.22 Sealed Air Corporation

8 MARKET OUTLOOK